These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33376540)

  • 1. Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis.
    Nie Y; Zhao Z; Chen M; Ma F; Fan Y; Kang Y; Kang B; Wang C
    Oncol Lett; 2021 Feb; 21(2):107. PubMed ID: 33376540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
    Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
    BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Anillin (ANLN) is correlated with colorectal cancer progression and poor prognosis.
    Wang G; Shen W; Cui L; Chen W; Hu X; Fu J
    Cancer Biomark; 2016; 16(3):459-65. PubMed ID: 27062703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen type VII α1 chain: A promising prognostic and immune infiltration biomarker of pancreatic cancer.
    Ding C; Yu Z; Li X; Zhu J; Dai M; He Q
    Oncol Lett; 2023 Feb; 25(2):77. PubMed ID: 36742365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer.
    Wang H; Guo H; Sun J; Wang Y
    Sci Rep; 2023 Aug; 13(1):13564. PubMed ID: 37604837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implication and immunological landscape analyses of ANLN in pan-cancer: A new target for cancer research.
    Zhang L; Wei Y; He Y; Wang X; Huang Z; Sun L; Chen J; Zhu Q; Zhou X
    Cancer Med; 2023 Feb; 12(4):4907-4920. PubMed ID: 36030492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of ANLN in lung adenocarcinoma.
    Long X; Zhou W; Wang Y; Liu S
    Oncol Lett; 2018 Aug; 16(2):1835-1840. PubMed ID: 30008873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive bioinformatics analysis reveals the prognostic value, predictive value, and immunological roles of ANLN in human cancers.
    Cui Z; Mo J; Song P; Wang L; Wang R; Cheng F; Wang L; Zou F; Guan X; Zheng N; Yang X; Wang W
    Front Genet; 2022; 13():1000339. PubMed ID: 36199577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of actin-binding protein ANLN by antitumor
    Idichi T; Seki N; Kurahara H; Yonemori K; Osako Y; Arai T; Okato A; Kita Y; Arigami T; Mataki Y; Kijima Y; Maemura K; Natsugoe S
    Oncotarget; 2017 Aug; 8(32):53180-53193. PubMed ID: 28881803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-gene-based prognostic signature for pancreatic cancer.
    Zhou S; Yan Y; Chen X; Zeng S; Wei J; Wang X; Gong Z; Xu Z
    Aging (Albany NY); 2020 Sep; 12(18):18322-18342. PubMed ID: 32966237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.
    Zeng S; Yu X; Ma C; Song R; Zhang Z; Zi X; Chen X; Wang Y; Yu Y; Zhao J; Wei R; Sun Y; Xu C
    Sci Rep; 2017 Jun; 7(1):3151. PubMed ID: 28600503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatic Analysis of Prognostic and Immune-Related Genes in Pancreatic Cancer.
    Li Z; Hu C; Yang Z; Yang M; Fang J; Zhou X
    Comput Math Methods Med; 2021; 2021():5549298. PubMed ID: 34394706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma.
    Zhang LH; Wang D; Li Z; Wang G; Chen DB; Cheng Q; Hu SH; Zhu JY
    Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):337-344. PubMed ID: 32933876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity.
    Zhang X; Li L; Huang S; Liao W; Li J; Huang Z; Huang Y; Lian Y
    Oxid Med Cell Longev; 2022; 2022():5322929. PubMed ID: 35340220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
    Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
    Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcellular localisation of anillin is associated with different survival outcomes in upper urinary tract urothelial carcinoma.
    Liang PI; Chen WT; Li CF; Li CC; Li WM; Huang CN; Yeh HC; Ke HL; Wu WJ; Chai CY
    J Clin Pathol; 2015 Dec; 68(12):1026-32. PubMed ID: 26135313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of MMP28 indicates unfavorable prognosis in pancreatic cancer.
    Chen Z; Huang J; Li M; Zhang L; Wan D; Lin S
    Medicine (Baltimore); 2021 Mar; 100(12):e25320. PubMed ID: 33761734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers.
    Shi Y; Ma X; Wang M; Lan S; Jian H; Wang Y; Wei Q; Zhong F
    Cancer Cell Int; 2022 May; 22(1):188. PubMed ID: 35568883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening
    Yang T; Chi Z; Liu G; Hong X; Cao S; Cheng K; Zhang Y
    Front Genet; 2023; 14():1107625. PubMed ID: 37051591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.